According to the American College of Obstetricians & Gynecologists, there are roughly 27 million American women in the peri- to post-menopausal years–that’s 20% of the US work force. And each year, roughly 2 million American women reach menopause.
Women betwen the ages of 50-60 years have a 3.5-fold higher risk of osteoarthritis than men of the same age. OA in post-menopausal women tends to be more severe and affects more joints.
In this free webinar, Dr. Anita Baxas, MD D.PSc, explores the relationship of bone and cartilage remodeling to OA in the menopausal milieu, and the role of Bone Morphogenic Proteins (BMPs) in supporting menopausal women at risk for OA.
Many clinicians do not recognize the cross-talk between dysregulated subchondral bone and cartilage, and the cascading impact it has on their post-menopausal patients. Learn how bone remodeling dysregulation influences the joint micro-environment, leading to the onset and exacerbation of OA in post-menopausal women.
During this webinar Dr. Baxas will share:
- Factors that alter the articular joint micro-environment.
- Insights on the structure and function of BMPs within Bone & Cartilage homeostasis.
- The dual immodulating and osteoinductive effects of BMPs
- Clinical experiences using Ostinol® in her osteoporosis treatments.
- Case Studies
- Personal practice protocol for post-menopausal OA
Sponsored by : REGENERATIVE TISSUE SCIENCE
